Discovery of 5-(or 6)-benzoxazoles and oxazolo[4,5-b]pyridines as novel candidate antitumor agents targeting hTopo IIα.


Journal

Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703

Informations de publication

Date de publication:
07 2021
Historique:
received: 06 12 2020
revised: 11 03 2021
accepted: 11 04 2021
pubmed: 5 5 2021
medline: 25 2 2023
entrez: 4 5 2021
Statut: ppublish

Résumé

Discovery of novel anticancer drugs which have low toxicity and high activity is very significant area in anticancer drug research and development. One of the important targets for cancer treatment research is topoisomerase enzymes. In order to make a contribution to this field, we have designed and synthesized some 5(or 6)-nitro-2-(substitutedphenyl)benzoxazole (1a-1r) and 2-(substitutedphenyl)oxazolo[4,5-b]pyridine (2a-2i) derivatives as novel candidate antitumor agents targeting human DNA topoisomerase enzymes (hTopo I and hTopo IIα). Biological activity results were found very promising for the future due to two compounds, 5-nitro-2-(4-butylphenyl)benzoxazole (1i) and 2-(4-butylphenyl)oxazolo[4,5-b]pyridine (2i), that inhibited hTopo IIα with 2 µM IC

Identifiants

pubmed: 33945950
pii: S0045-2068(21)00290-X
doi: 10.1016/j.bioorg.2021.104913
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Benzoxazoles 0
Oxazoles 0
Pyrimidines 0
Topoisomerase II Inhibitors 0
oxazolo(5,4-d)pyrimidine 0
DNA Topoisomerases, Type II EC 5.99.1.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104913

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Esin Karatas (E)

Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ankara, Turkey.

Egemen Foto (E)

Necmettin Erbakan University, Faculty of Science, Department of Biotechnology, Konya, Turkey.

Tugba Ertan-Bolelli (T)

Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ankara, Turkey.

Gozde Yalcin-Ozkat (G)

Ankara University, Biotechnology Institute, 0fef0 Yenimahalle, Ankara, Turkey; Recep Tayyip Erdogan University, Faculty of Engineering, Bioengineering Department, Rize, Turkey.

Serap Yilmaz (S)

Trakya University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Edirne, Turkey.

Sanaz Ataei (S)

Ankara University, Biotechnology Institute, 0fef0 Yenimahalle, Ankara, Turkey.

Fatma Zilifdar (F)

Selcuk University Faculty of Science, Department of Biochemistry, Konya, Turkey.

Ilkay Yildiz (I)

Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ankara, Turkey. Electronic address: iyildiz@pharmacy.ankara.edu.tr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH